MarketBeat Instant News Alerts 2 hours agoBel Fuse (NASDAQ:BELFA) Receives Hold (C) Rating from Weiss RatingsMarketBeatWeiss Ratings restated a "hold (c)" rating on shares of Bel Fuse in a research note on Friday.NASDAQ:BELFARead Bel Fuse (NASDAQ:BELFA) Receives Hold (C) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (E+)" Rating for Mobile Infrastructure (NASDAQ:BEEP)MarketBeatWeiss Ratings restated a "sell (e+)" rating on shares of Mobile Infrastructure in a report on Friday.NASDAQ:BEEPRead Weiss Ratings Reiterates "Sell (E+)" Rating for Mobile Infrastructure (NASDAQ:BEEP)2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for Beam Global (NASDAQ:BEEM)MarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of Beam Global in a research note on Friday.NASDAQ:BEEMRead Weiss Ratings Reiterates Sell (D-) Rating for Beam Global (NASDAQ:BEEM)2 hours agoBeam Therapeutics (NASDAQ:BEAM) Earns Sell (D-) Rating from Weiss RatingsMarketBeatWeiss Ratings restated a "sell (d-)" rating on shares of Beam Therapeutics in a report on Friday.NASDAQ:BEAMRead Beam Therapeutics (NASDAQ:BEAM) Earns Sell (D-) Rating from Weiss Ratings2 hours agoBlack Diamond Therapeutics' (BDTX) "Sell (D)" Rating Reiterated at Weiss RatingsMarketBeatWeiss Ratings reissued a "sell (d)" rating on shares of Black Diamond Therapeutics in a report on Friday.NASDAQ:BDTXRead Black Diamond Therapeutics' (BDTX) "Sell (D)" Rating Reiterated at Weiss Ratings2 hours agoBioCryst Pharmaceuticals' (BCRX) Sell (D-) Rating Reaffirmed at Weiss RatingsMarketBeatWeiss Ratings reiterated a "sell (d-)" rating on shares of BioCryst Pharmaceuticals in a research note on Friday.NASDAQ:BCRXRead BioCryst Pharmaceuticals' (BCRX) Sell (D-) Rating Reaffirmed at Weiss Ratings Trending News1D-Wave Quantum (NYSE:QBTS) Stock Price Down 6.2% - Here's Why2Oracle (NYSE:ORCL) Stock Price Down 4.9% - Here's What Happened3Oracle (NYSE:ORCL) EVP Sells $1,403,100.00 in Stock4Nebius Group (NBIS) to Release Earnings on Wednesday5Plug Power (NASDAQ:PLUG) Shares Down 8.2% - Here's Why6Rolls-Royce Holdings plc (LON:RR) Shares Down 2.8% - Here's What Happened7Nebius Group (NASDAQ:NBIS) Shares Down 3.9% - Time to Sell?8Verizon Communications (NYSE:VZ) Stock Price Down 1.1% Following Analyst Downgrade All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoBay Commercial Bank's (BCML) Buy (B) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:BCMLRead Bay Commercial Bank's (BCML) Buy (B) Rating Reaffirmed at Weiss Ratings2 hours agoBCB Bancorp, Inc. (NJ)'s (BCBP) Sell (D+) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:BCBPRead BCB Bancorp, Inc. (NJ)'s (BCBP) Sell (D+) Rating Reaffirmed at Weiss Ratings2 hours agoCalifornia BanCorp's (BCAL) "Hold (C+)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:BCALRead California BanCorp's (BCAL) "Hold (C+)" Rating Reiterated at Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D)" Rating for Beta Bionics (NASDAQ:BBNX)MarketBeatNASDAQ:BBNXRead Weiss Ratings Reiterates "Sell (D)" Rating for Beta Bionics (NASDAQ:BBNX)2 hours agoBridgeBio Pharma (NASDAQ:BBIO) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:BBIORead BridgeBio Pharma (NASDAQ:BBIO) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Atlanta Braves (NASDAQ:BATRK)MarketBeatNASDAQ:BATRKRead Weiss Ratings Reiterates "Sell (D-)" Rating for Atlanta Braves (NASDAQ:BATRK)2 hours agoAtlanta Braves (NASDAQ:BATRA) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:BATRARead Atlanta Braves (NASDAQ:BATRA) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoBanner (NASDAQ:BANR) Stock Rating Lowered by Weiss RatingsMarketBeatNASDAQ:BANRRead Banner (NASDAQ:BANR) Stock Rating Lowered by Weiss Ratings2 hours agoBancFirst (NASDAQ:BANF) Given "Buy (B-)" Rating at Weiss RatingsMarketBeatNASDAQ:BANFRead BancFirst (NASDAQ:BANF) Given "Buy (B-)" Rating at Weiss Ratings2 hours agoBandwidth (NASDAQ:BAND) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:BANDRead Bandwidth (NASDAQ:BAND) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reaffirms "Sell (E)" Rating for Bleichroeder Acquisition Corp. I (NASDAQ:BACQ)MarketBeatNASDAQ:BACQRead Weiss Ratings Reaffirms "Sell (E)" Rating for Bleichroeder Acquisition Corp. I (NASDAQ:BACQ)2 hours agoAzenta's (AZTA) "Sell (D-)" Rating Reiterated at Weiss RatingsMarketBeatNASDAQ:AZTARead Azenta's (AZTA) "Sell (D-)" Rating Reiterated at Weiss Ratings2 hours agoAstraZeneca (NASDAQ:AZN) Given "Buy (B)" Rating at Weiss RatingsMarketBeatNASDAQ:AZNRead AstraZeneca (NASDAQ:AZN) Given "Buy (B)" Rating at Weiss Ratings2 hours agoAXT (NASDAQ:AXTI) Receives Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:AXTIRead AXT (NASDAQ:AXTI) Receives Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for Axsome Therapeutics (NASDAQ:AXSM)MarketBeatNASDAQ:AXSMRead Weiss Ratings Reiterates Sell (D-) Rating for Axsome Therapeutics (NASDAQ:AXSM)2 hours agoWeiss Ratings Reiterates "Hold (C)" Rating for Axon Enterprise (NASDAQ:AXON)MarketBeatNASDAQ:AXONRead Weiss Ratings Reiterates "Hold (C)" Rating for Axon Enterprise (NASDAQ:AXON)2 hours agoAxoGen (NASDAQ:AXGN) Earns Sell (D-) Rating from Weiss RatingsMarketBeatNASDAQ:AXGNRead AxoGen (NASDAQ:AXGN) Earns Sell (D-) Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates "Sell (D-)" Rating for Aware (NASDAQ:AWRE)MarketBeatNASDAQ:AWRERead Weiss Ratings Reiterates "Sell (D-)" Rating for Aware (NASDAQ:AWRE)2 hours agoAvnet (NASDAQ:AVT) Receives "Hold (C+)" Rating from Weiss RatingsMarketBeatNASDAQ:AVTRead Avnet (NASDAQ:AVT) Receives "Hold (C+)" Rating from Weiss Ratings2 hours agoWeiss Ratings Reiterates Sell (D-) Rating for AvePoint (NASDAQ:AVPT)MarketBeatNASDAQ:AVPTRead Weiss Ratings Reiterates Sell (D-) Rating for AvePoint (NASDAQ:AVPT)2 hours agoMission Produce's (AVO) Hold (C) Rating Reaffirmed at Weiss RatingsMarketBeatNASDAQ:AVORead Mission Produce's (AVO) Hold (C) Rating Reaffirmed at Weiss Ratings2 hours agoAtea Pharmaceuticals (NASDAQ:AVIR) Receives "Sell (D-)" Rating from Weiss RatingsMarketBeatNASDAQ:AVIRRead Atea Pharmaceuticals (NASDAQ:AVIR) Receives "Sell (D-)" Rating from Weiss Ratings2 hours agoInterContinental Hotels Group (LON:IHG) Given New GBX 8,000 Price Target at CitigroupMarketBeatLON:IHGRead InterContinental Hotels Group (LON:IHG) Given New GBX 8,000 Price Target at Citigroup2 hours agoRentokil Initial plc (LON:RTO) Given Average Recommendation of "Hold" by BrokeragesMarketBeatLON:RTORead Rentokil Initial plc (LON:RTO) Given Average Recommendation of "Hold" by Brokerages Featured Articles and OffersJPMorgan Crushes Q3; But Is the Steady Eddy Stock Hitting A Wall?By Leo Miller | October 19, 2025Robinhood warningFrom Stansberry Research (Ad)Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetBy Dan Schmidt | October 20, 2025Archer’s Recent String of Victories Signals a New Phase of GrowthBy Jeffrey Neal Johnson | October 22, 2025The Best AI for Picking Stocks, Ranked by PerformanceBy Thomas Hughes | October 23, 2025Buffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyFrom Banyan Hill Publishing (Ad)2 Ways to Trade Qualcomm Ahead of November’s EarningsBy Sam Quirke | October 21, 2025Warner Bros. Bidding War Potential: How High Could WBD Shares Go?By Leo Miller | October 23, 2025 Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
